Introduction to sequencing by binding
Since acquiring Omniome, PacBio is uniquely positioned as the only company with both highly accurate native long-read and short-read sequencing platforms. The integration of these complementary technologies will enable PacBio to dramatically expand its market opportunity for sequencing in novel ways, providing more value to customers across the broadest spectrum of applications.
We believe that sequencing by binding (SBB®) will be a key player in the future of short-read sequencing. Our proprietary technology creates unparalleled next generation sequencing (NGS) opportunities by improving access to molecular information.
Under development since 2013, SBB technology has the potential to deliver unsurpassed sequencing accuracy. It is a highly differentiated solution that aims to advance cancer diagnostics, drive higher fidelity for single-cell applications, and broadly enable clinical sequencing.
Sequencing by binding solutions
Providing opportunities for screening, monitoring, and therapy selection
Enabling gene editing and environmental monitoring
Fueling advances in cell transplant and organ transplant
Unlocking discovery and potential clinical application for NIPT and rare and inherited disease
New possibilities for
next generation sequencing
The accuracy of SBB’s novel sequencing approach has the potential to advance cancer diagnostics, drive higher fidelity for single-cell applications, and broadly enable clinical sequencing — even in regions of the genome prone to sequencing errors.
The groundbreaking engineering of the short-read sequencing platform that enables SBB will offer significantly faster data collection and throughput expansion at a lower cost than traditional NGS platforms.
The development of SBB technology redefines how technology is created. By collaborating deeply, we are reimagining genomics applications without boundaries.
We seek partners to define what the scientific community needs most so that we can shape the technology and make an impact.
Our collaboration drives discovery and potential therapies to those in need.